etalaze

Etalaze

Long time customer of Etalaze, always come through. This time around I got Dragon Pharma’s EQ / Test E 200 injectable and used it as a pre workout. I also got some dragon pharma arimidex and dragon pharma test e 250. first of all the eq/test e mix is the shit!! Anyone that has tried Read more about Etalaze[…]

Abbott’s Synthroid Faces Removal

Follow my blog with Bloglovin The Food and Drug Administration has told the makers of Synthroid, the third most frequently prescribed drug in the U.S., that the medicine has a “history of problems” and cannot be recognized as “safe and effective.”The agency’s statements raise the possibility that the 40-year-old drug, which has never been officially Read more about Abbott’s Synthroid Faces Removal[…]

AltaRex Licenses U.S. Issued Patents

AltaRex Corp. has obtained an exclusive worldwide license for a family of four U.S issued patents and foreign counterparts from the Alberta Research Council, Inc. (ARC) in Edmonton, Alberta. These additions to the Company’s intellectual property portfolio provide AltaRex with a strong foundation for developing novel treatments in the area of autoimmune/inflammatory disease, such as Read more about AltaRex Licenses U.S. Issued Patents[…]

Scios And Medtronic To Develop Heart Failure Treatment

Scios Inc. has announced its entry into a research collaboration with Medtronic, Inc. to study the effects of Scios’ investigational agent Natrecor (nesiritide) in combination with Medtronic’s heart failure devices and implantable infusion systems. “We are excited to establish this collaboration as both Scios and Medtronic have a shared commitment to the diagnosis and management Read more about Scios And Medtronic To Develop Heart Failure Treatment[…]

Cell Pathways And Squibb Agree Joint Study

Cell Pathways, Inc. and Bristol-Myers Squibb Company plan to cooperate in supporting a clinical trial to study the combination of Aptosyn (exisulind) and TAXOL (paclitaxel) plus Paraplatin (carboplatin) as a first-line treatment for patients with advanced non- small cell lung cancer (NSCLC). This Phase I/II study is designed to evaluate escalating doses of Aptosyn in Read more about Cell Pathways And Squibb Agree Joint Study[…]

abbott laboratories

Idun And Abbott Extend Partnership Agreement

Idun Pharmaceuticals, Inc. has extended their worldwide research and development agreement with Abbott Laboratories focusing on the discovery and development of products to treat people with cancer. Under this agreement, Abbott and Idun will continue their collaboration to discover drugs that regulate the activity of specific proteins involved in the cell pathways leading to programmed Read more about Idun And Abbott Extend Partnership Agreement[…]

Interneuron Licenses Treatment For Liver Disease

Interneuron Pharmaceuticals, Inc. has exercised its option and entered into an agreement to license IP 501, an orally-administered anti-fibrotic purified phospholipid compound in Phase 3 development for the treatment and prevention of liver diseases, including alcohol and Hepatitis C-induced cirrhosis. The license agreement gives Interneuron rights to develop and commercialise the drug in several major Read more about Interneuron Licenses Treatment For Liver Disease[…]

Study Reports Link Between Alzheimer’s Cellular Abnormalities

Neurogenetics, Inc. has reported that a study published in the September issue of Neuron links a new mechanism-based therapeutic approach, licensed by the Company from Massachusetts General Hospital (MGH), to Alzheimer’s disease (AD). Researchers from the MGH Genetics and Aging Unit report that they have discovered a key link between two cellular abnormalities associated with Read more about Study Reports Link Between Alzheimer’s Cellular Abnormalities[…]

Pompe Disease Therapy Receives Orphan Designation

Novazyme Pharmaceuticals, Inc. has received formal notification from the Office of Orphan Products Development at the FDA that its proprietary, highly phosphorylated enzyme replacement therapy for the treatment of Pompe Disease has been granted orphan drug status. This notification from the FDA represents the first official validation of Novazyme‘s core phosphorylation technology platform with which Read more about Pompe Disease Therapy Receives Orphan Designation[…]

Coulter Acquires Rights To Novel Technology

Coulter Pharmaceutical, Inc. has entered into a license and research agreement with Yissum, the technology transfer company of Hebrew University, for technology, know-how and worldwide intellectual property rights relating to a novel approach to treating rheumatoid arthritis (RA). This new approach involves reducing RA joint inflammation by targeting the synovial cells responsible for infiltrating and Read more about Coulter Acquires Rights To Novel Technology[…]

Buy Dragon Pharmaceutical of Top Quality

Sustanon 350 - Cheap Price

Administration: Injection
Primary Constituent: Testosterone Blend
Producer: Dragon Pharmaceutical
Unit: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00

Oxymetholon - Bulk Price

Administration: Oral
Basal Chemical Name: Oxymetholone
Made by: Dragon Pharma Labs
Pack: 10 x 100 tabs (50 mg/tablet)
Price: 10 x $65.00

NPP 150 - Cheap Price

Administration: Injection
Prime Chemical Name: Nandrolone Phenylpropionate
Made by: Dragon Pharma LLC
Unit: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $25.00

Clenbuterol - Cheap Price

Administration: Oral
Active Substance: Clenbuterol Hydrochloride
Manufacturer: Dragon Pharma
Amount: 20 x 100 pills (40 mcg/tab)
Price: 20 x $25

Suspension 100

Injectable Anabolic Steroid
Active Ingredient: Testosterone Suspension
Producer: Dragon Pharma LLC
Unit: 1 X 10 ml (100 mg/ml)

Parabolan 100 - Bulk Price

Administration: Injection
Base Component: Trenbolone Hexahydrobenzylcarbonate
Manufacturer: Dragon Pharma
Amount: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $69.00

Parabolan 100

Injectable Anabolic Steroid
Principal Ingredient: Trenbolone Hexahydrobenzylcarbonate
Producer: Dragon Pharmaceutical
Package: 1 X 10 ml (100 mg/ml)

Sustanon 350 - Discount Price

Administration: Injection
Principal Component: Testosterone Blend
Made by: Dragon Pharma Labs
Unit: 30 x 10 mL vial (350 mg/mL)
Price: 30 x $32.00

Primobolan 100

Injectable Steroid for Muscle Growth
Basal Ingredient: Methenolone Enanthate
Producer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (100 mg/mL)

Cut Mix 150

Injectable Steroid for Muscle Growth
Mix of: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharmaceutical
10 mL Sterile Multi-dose Vial (150 mg/mL)

1-Test Cyp 200

Injectable Steroid for Muscle Growth
Active Substance: Dihydroboldenone Cypionate
Branded by: Dragon Pharma
10 mL Sterile Multi-dose Vial (200 mg/mL)

Sustanon 350

Injectable Steroid for Muscle Growth
Mix of: Testosterone Decanoate,
Testosterone Isocaproate, Testosterone PhenylPropionate, Testosterone Propionate
Producer: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (350 mg/mL)